Results 341 to 350 of about 1,818,460 (375)

Mixed Neuroendocrine–Non‐Neuroendocrine Tumor of Bile Duct

The Kaohsiung Journal of Medical Sciences, EarlyView.
Lian Shen, Wei‐Nan Liu, Shuo Qi, Chang‐Jun Liu   +3 more
wiley   +1 more source

The diagnostic value of contrast-enhanced ultrasound combined with clinicopathological features in microinvasive ductal carcinoma in situ. [PDF]

Gland Surg
Jiang Y, Li JK, Huang SS, Li SY, Niu RL, Fu NQ, Wang ZL.   +6 more
europepmc   +1 more source

Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk. [PDF]

Gland Surg
Rizk M, Oner M, Mokbel K.
europepmc   +1 more source

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

JAMA
Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH, COMET Study Investigators.   +37 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ductal Carcinoma In Situ

Surgical Clinics of North America, 2018
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng Fu, Richard C. Gilmore, Lisa K. Jacobs   +2 more
  +9 more sources

Squamoid Eccrine Ductal Carcinoma

Cutis, 2021
Squamoid eccrine ductal carcinoma (SEDC) is a rare and under-recognized primary cutaneous tumor with a high risk for local recurrence and metastasis. The tumor has a biphasic histologic appearance consisting of a superficial portion indistinguishable from squamous cell carcinoma (SCC) and a deeper component demonstrating eccrine ductal differentiation.
Mariana A Phillips, Douglas J Grider, Steven A Svoboda, Craig J Garofola, Patrick S Rush, Kyle A Prickett   +5 more
openaire   +2 more sources

Ductal carcinoma in situ

Surgical Clinics of North America, 2003
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina Nakhlis, Monica Morrow
openaire   +2 more sources